B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer

[1] Fleisher B(2016)Current advances in biomarkers for targeted therapy in triple-negative breast cancer Breast Cancer 8 183-197

[2] Clarke C(2016)Triple-negative breast cancer: is there a treatment on the horizon? Oncotarget 8 1913-690

[3] Ait-Oudhia S(2016)Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease Nat Rev Clin Oncol 13 674-359

[4] Yao H(2016)Concepts and targets in triple-negative breast cancer: recent results and clinical implications Ther Adv Med Oncol 8 351-103

[5] He G(2016)Targeted therapy for breast cancer and molecular mechanisms of resistance to treatment Curr Opin Pharmacol 31 97-578

[6] Yan S(2016)Systematic drug screening identifies tractable targeted combination therapies in triple-negative breast cancer Cancer Res 77 566-2771

[7] Chen C(2016)The impact of chemotherapy, radiation and epigenetic modifiers in cancer cell expression of immune inhibitory and stimulatory molecules and anti-tumor efficacy Vaccines 4 43-1211

[8] Song L(2014)B7-H3-mediated tumor immunology: friend or foe? Int J Cancer 134 2764-260

[9] Rosol TJ(2016)Mismatch repair deficiency and response to immune checkpoint blockade Oncologist 21 1200-548

[10] Deng X(2016)Immunobiology and immunotherapy in genitourinary malignancies Ann Transl Med 4 270-861

[1] Fleisher B(2016)Current advances in biomarkers for targeted therapy in triple-negative breast cancer Breast Cancer 8 183-197

[2] Clarke C(2016)Triple-negative breast cancer: is there a treatment on the horizon? Oncotarget 8 1913-690

[3] Ait-Oudhia S(2016)Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease Nat Rev Clin Oncol 13 674-359

[4] Yao H(2016)Concepts and targets in triple-negative breast cancer: recent results and clinical implications Ther Adv Med Oncol 8 351-103

[5] He G(2016)Targeted therapy for breast cancer and molecular mechanisms of resistance to treatment Curr Opin Pharmacol 31 97-578

[6] Yan S(2016)Systematic drug screening identifies tractable targeted combination therapies in triple-negative breast cancer Cancer Res 77 566-2771

[7] Chen C(2016)The impact of chemotherapy, radiation and epigenetic modifiers in cancer cell expression of immune inhibitory and stimulatory molecules and anti-tumor efficacy Vaccines 4 43-1211

[8] Song L(2014)B7-H3-mediated tumor immunology: friend or foe? Int J Cancer 134 2764-260

[9] Rosol TJ(2016)Mismatch repair deficiency and response to immune checkpoint blockade Oncologist 21 1200-548

[10] Deng X(2016)Immunobiology and immunotherapy in genitourinary malignancies Ann Transl Med 4 270-861